Variant report
Variant | esv3339155 |
---|---|
Chromosome Location | chr12:11333485-11337883 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:24)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:24 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr12:11335667-11335960 | GM12878 | blood: | n/a | chr12:11335847-11335858 |
2 | BCL3 | chr12:11335602-11335966 | GM12878 | blood: | n/a | n/a |
3 | CEBPB | chr12:11337543-11337617 | HepG2 | liver: | n/a | chr12:11337560-11337571 |
4 | CEBPB | chr12:11335223-11335465 | HepG2 | liver: | n/a | chr12:11335342-11335353 |
5 | CEBPB | chr12:11335205-11335458 | A549 | lung: | n/a | chr12:11335342-11335353 |
6 | CEBPB | chr12:11335197-11335487 | Hela-S3 | cervix: | n/a | chr12:11335342-11335353 |
7 | CEBPB | chr12:11335237-11335433 | K562 | blood: | n/a | chr12:11335342-11335353 |
8 | CEBPB | chr12:11335214-11335440 | IMR90 | lung: | n/a | chr12:11335342-11335353 |
9 | EP300 | chr12:11335785-11335844 | GM12878 | blood: | n/a | n/a |
10 | FOS | chr12:11335231-11335431 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | FOS | chr12:11335222-11335444 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | FOS | chr12:11335231-11335393 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | FOXM1 | chr12:11335569-11335924 | GM12878 | blood: | n/a | n/a |
14 | GATA3 | chr12:11333303-11333503 | SH-SY5Y | brain: | n/a | n/a |
15 | GATA3 | chr12:11335521-11335982 | MCF-7 | breast: | n/a | chr12:11335699-11335708 |
16 | MYC | chr12:11334468-11334509 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | NFIC | chr12:11335552-11335973 | GM12878 | blood: | n/a | n/a |
18 | POLR2A | chr12:11334282-11334330 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | RUNX3 | chr12:11335560-11336072 | GM12878 | blood: | n/a | n/a |
20 | RUNX3 | chr12:11335592-11336026 | GM12878 | blood: | n/a | n/a |
21 | STAT3 | chr12:11335260-11335448 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | STAT3 | chr12:11335755-11335955 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | STAT3 | chr12:11334511-11334711 | MCF10A-Er-Src | breast: | n/a | chr12:11334699-11334710 |
24 | STAT5A | chr12:11335645-11336004 | GM12878 | blood: | n/a | n/a |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:11328652..11331846-chr12:11337152..11339281,3 | MCF-7 | breast: | |
2 | chr12:11321748..11327565-chr12:11327784..11333912,14 | MCF-7 | breast: | |
3 | chr12:11322782..11326787-chr12:11332516..11335699,5 | K562 | blood: | |
4 | chr12:11331591..11333492-chr12:11338114..11339808,2 | K562 | blood: | |
5 | chr12:11328230..11331736-chr12:11334279..11336008,3 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
TAS2R67P | TF binding region |
ENSG00000212127 | chromatin interactions |
ENSG00000256712 | chromatin interactions |
ENSG00000256537 | chromatin interactions |
ENSG00000111215 | chromatin interactions |
ENSG00000186136 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs319270 | chr12:11333542-11333543 | Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs370744190 | chr12:11333568-11333569 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
3 | rs529002909 | chr12:11333594-11333595 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
4 | rs36002931 | chr12:11333613-11333614 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
5 | rs1451766 | chr12:11333632-11333633 | Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs319271 | chr12:11333633-11333634 | Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs74999883 | chr12:11333647-11333648 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
8 | rs150770891 | chr12:11333716-11333717 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
9 | rs143196376 | chr12:11333753-11333754 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
10 | rs539348445 | chr12:11333782-11333783 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
11 | rs142502269 | chr12:11333861-11333862 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
12 | rs193031390 | chr12:11333965-11333966 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
13 | rs553309776 | chr12:11334064-11334065 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
14 | rs573411772 | chr12:11334080-11334081 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
15 | rs139169100 | chr12:11334103-11334104 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
16 | rs376683494 | chr12:11334175-11334176 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs558900348 | chr12:11334237-11334238 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
18 | rs555936681 | chr12:11334259-11334260 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
19 | rs149947048 | chr12:11334260-11334261 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
20 | rs544620121 | chr12:11334273-11334274 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
21 | rs370792715 | chr12:11334320-11334321 | Weak transcription | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
22 | rs564432867 | chr12:11334342-11334343 | Weak transcription | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
23 | rs319272 | chr12:11334369-11334370 | Weak transcription | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs112632894 | chr12:11334410-11334411 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
25 | rs139794842 | chr12:11334411-11334412 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
26 | rs529122648 | chr12:11334463-11334464 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
27 | rs143148953 | chr12:11334505-11334506 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
28 | rs530294711 | chr12:11334637-11334638 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
29 | rs562291756 | chr12:11334645-11334646 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
30 | rs146673089 | chr12:11334662-11334663 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
31 | rs184410393 | chr12:11334715-11334716 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
32 | rs571191345 | chr12:11334832-11334833 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
33 | rs319273 | chr12:11334853-11334854 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs35470561 | chr12:11334860-11334861 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs375203091 | chr12:11334894-11334895 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
36 | rs567043135 | chr12:11334959-11334960 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
37 | rs536102598 | chr12:11334962-11334963 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
38 | rs140286292 | chr12:11334978-11334979 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
39 | rs575817697 | chr12:11334986-11334987 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
40 | rs542815054 | chr12:11334991-11334992 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
41 | rs570354193 | chr12:11334999-11335000 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
42 | rs188752818 | chr12:11335126-11335127 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
43 | rs559614003 | chr12:11335152-11335153 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
44 | rs577992629 | chr12:11335164-11335165 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
45 | rs142584383 | chr12:11335171-11335172 | Weak transcription Enhancers | Chromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
46 | rs35449580 | chr12:11335221-11335222 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
47 | rs201611166 | chr12:11335223-11335224 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
48 | rs397763588 | chr12:11335224-11335225 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
49 | rs376903759 | chr12:11335285-11335286 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
50 | rs151078410 | chr12:11335304-11335305 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 17690704 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Breast cancer | 22032731 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 21965145 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Prostate cancer | 19156837 | CNVD |
Emphysema | 19352772 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16461572 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:11325000-11335600 | Weak transcription | Left Ventricle | heart |
2 | chr12:11325600-11334400 | Weak transcription | Primary B cells from cord blood | blood |
3 | chr12:11325600-11338200 | Weak transcription | Primary B cells from peripheral blood | blood |
4 | chr12:11326000-11334400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
5 | chr12:11326200-11334600 | Weak transcription | Liver | Liver |
6 | chr12:11326200-11338600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
7 | chr12:11326400-11334400 | Weak transcription | Fetal Thymus | thymus |
8 | chr12:11326400-11337400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr12:11326400-11355600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr12:11328000-11338600 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
11 | chr12:11328600-11334400 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
12 | chr12:11328800-11340400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr12:11330600-11365400 | Weak transcription | Primary T cells from cord blood | blood |
14 | chr12:11334400-11334600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
15 | chr12:11334400-11334800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
16 | chr12:11334600-11336000 | Enhancers | Liver | Liver |
17 | chr12:11334800-11335000 | Enhancers | Brain Germinal Matrix | brain |
18 | chr12:11335800-11336000 | Enhancers | Left Ventricle | heart |
19 | chr12:11337400-11337600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |